PubMed

Towards a feature-based regulatory benchmark for user-centred SaMD design in cancer care.

PMID: 42173550 · 2026-05-22

S, a, b, a, , K, h, e, i, r, i, n, e, j, a, d, ;, , C, h, r, i, s, t, o, p, h, e, r, , L, , B, r, e, t, t, ;, , R, o, b, e, r, t, , L, , D, a, v, i, s, ;, , D, a, v, i, d, , L, , S, c, h, w, a, r, t, z, ;, , A, r, a, s, h, , S, h, a, b, a, n, -, N, e, j, a, d

학술지BMJ health & care informatics

연도2026-05-22

PMID42173550

초록

Software as a medical device (SaMD) is increasingly central to cancer care, yet current regulatory frameworks from the International Medical Device Regulators, the US Food and Drug Administration and the European Medical Device Regulation lack clear premarket standards for evaluating usability, accessibility and emotional/cultural appropriateness for intended users. This gap is particularly problematic in oncology, where patients, caregivers and clinicians navigate high cognitive load, emotional

공식 출처

PubMed에서 보기 →

데이터는 PubMed / NCBI에서 제공됩니다. 전문과 최신 정보는 반드시 공식 기록을 확인하세요.